Skip to main content

Want a detailed portfolio tracker?

Omeros (OMER) P/E (2011 - 2026)

Omeros (OMER) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Omeros (OMER) P/E is 8.51. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Omeros (OMER)

YearP/EChange
20268.51-111.63%
2025-73.14+1902.76%
2024-3.65-135.59%
202310.26+1345.68%
20220.71-65.82%
20212.08-134.47%
2020-6.02-28.96%
2019-8.48+98.07%
2018-4.28-72.01%
2017-15.29+160.98%
2016-5.86-26.24%
2015-7.94-30.60%
2014-11.45+40.50%
2013-8.15+149.15%
2012-3.27-31.42%
2011-4.77N/A

Comparison Omeros (OMER) P/E with competitors

Omeros (OMER) P/E is 8.51.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.98%
NBYStablecoin Development Corp0.00-99.95%
ENLVEnlivex Ltd0.07-99.12%
FGENFibroGen Inc0.24-97.18%
CHRSCoherus Biosciences Inc0.85-90.03%
FBIOFortress Biotech Inc0.95-88.85%
ORMPOramed Pharmaceuticals Inc1.50-82.33%
AGENAgenus Inc3.01-64.63%
INVAInnoviva Inc3.15-62.93%
VXRTVaxart Inc3.55-58.28%
CRMDCorMedix Inc3.63-57.36%
CVACCureVac N.V.4.45-47.75%
GLPGGalapagos NV4.86-42.89%
SRPTSarepta Therapeutics Inc4.88-42.62%
ABEOAbeona Therapeutics Inc5.39-36.68%
ABUSArbutus Biopharma Corp5.60-34.24%
ZVRAZevra Therapeutics Inc5.89-30.81%
SPROSpero Therapeutics Inc6.23-26.80%
CGENCompugen Ltd6.31-25.79%
RIGLRigel Pharmaceuticals6.87-19.23%
SLXNSilexion Therapeutics Corp7.30-14.25%
AUPHAurinia Pharmaceuticals Inc9.58+12.65%
PLXProtalix BioTherapeutics Inc10.89+28.00%
ACADAcadia Pharmaceuticals Inc11.73+37.84%
TBPHTheravance Biopharma Inc12.26+44.11%
ADMAAdma Biologics Inc12.42+45.95%
HRMYHarmony Biosciences Holdings Inc13.82+62.43%
SABSSAB Biotherapeutics Inc14.14+66.14%
NAGENiagen Bioscience Inc14.82+74.15%
INCYIncyte Corp15.82+85.96%
REGNRegeneron Pharmaceuticals Inc15.86+86.36%
PBYIPuma Biotechnology Inc17.32+103.51%
CPRXCatalyst Pharmaceuticals Inc17.44+104.96%
EXELExelixis Inc17.54+106.12%
TGTXTG Therapeutics Inc18.97+122.90%
MDXGMimedx Group Inc20.55+141.55%
XOMAXOMA Royalty Corp22.87+168.85%
ARGXArgen X SE24.30+185.58%
CTMXCytomX Therapeutics Inc24.82+191.72%
XOMAOXOMA Royalty Corp25.34+197.88%
HALOHalozyme Therapeutics Inc25.62+201.16%
XOMAPXOMA Royalty Corp25.67+201.70%
VRTXVertex Pharmaceuticals Inc27.99+229.02%
RPRXRoyalty Pharma plc - Class A28.69+237.17%
SLNOSoleno Therapeutics Inc29.02+241.02%
ASNDAscendis Pharma A/S30.09+253.60%
LGNDLigand Pharmaceuticals Inc - Class B37.91+345.58%
APLSApellis Pharmaceuticals Inc39.02+358.62%
BMRNBiomarin Pharmaceutical Inc42.21+396.12%
KRYSKrystal Biotech Inc45.34+432.92%
PHARPharming Group N.V.75.03+781.78%
TECHBio-Techne Corp101.96+1098.32%
VCELVericel Corp109.92+1191.91%
ALNYAlnylam Pharmaceuticals Inc117.96+1286.45%
GMABGenmab140.29+1548.85%
TLXTelix Pharmaceuticals Ltd162.15+1805.79%
CORTCorcept Therapeutics Inc212.86+2401.73%